Navigation Links
Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
Date:9/21/2007

o osteoporosis product candidates in pre-clinical studies. For further information regarding Biodel, please visit the Company's website at http://www.biodel.com.

Safe Harbor

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other then statements of historical facts, including statements regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management are forward- looking statements. The words "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "projects," "should," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company's forward-looking statements are subject to a number of known and unknown risks and uncertainties that could cause actual results, performance or achievements to differ materially from those described or implied in the forward-looking statements, including, but not limited to, our ability to secure FDA approval for our product candidates under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act; our ability to market, commercialize and achieve market acceptance for product candidates developed using our VIAdel(TM) technology; the progress or success of our research, development and clinical programs, the initiation and completion of our clinical trials, the timing of the interim analyses and the timing or success of our product candidates, particularly VIAject(TM) and VIAtab(TM); our ability to secure patents for VIAject(TM) and our other product candidates; our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others; our estimates of futu
'/>"/>

SOURCE Biodel Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Biodel Inc. to Present VIAject Clinical Progress at the 2007 American Diabetes Association Meeting
2. PromegaExpress Expands Easy Access to Products with New Cabinet
3. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
4. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
5. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
6. Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  MGC Diagnostics Corporation (NASDAQ: ... medical technology company, today scheduled a conference call to ... fiscal year 2013, ended April 30, 2013. The call ... 30, 2013. The Company will report financial results for ... markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... 2013  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: ... based on intellectual property developed and owned by ... foremost medical research center, today announced that its ... funding from the Israeli Ministry of Industry and ... support product development and advance clinical trials. Cell ...
(Date:5/23/2013)... Calif. , May 23, 2013 Anthem ... program that would have required them to obtain their ... by Consumer Watchdog and Whatley Kallas LLC.  ... Superior Court, alleged that Blue Cross,s mandatory mail order ... threatening their health and privacy. "This settlement ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
(Date:5/24/2013)... Atlanta, GA (PRWEB) May 24, 2013 CBT ... of Sales. Gonter joins the web-based retail automotive industry news ... sales. , “I’m excited to join a group that’s ... a perfect example of how online video content is on ... career in the motorcycle business and segued into advertising at ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Electric™ Energy Straws, ... fueling IndyCar Rookie Carlos Munoz and will be the lead ... 500 at the Indianapolis Motor Speedway. Munoz, who is part ... speed of 228.342 mph in race, qualifying to be named ... the first row in Sunday’s race. , While Munoz ...
(Date:5/24/2013)... York, NY (PRWEB) May 24, 2013 ... Antigua (AICASA) has signed an articulation agreement with ... their students to study abroad in Antigua. ... three college credits after participating in a cell biology ... an articulation agreement with American University of Antigua ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 The ... of products used outside the central laboratory, by ... a healthcare practitioner or by consumers. This includes ... fertility and pregnancy, infectious and cardiovascular disease and ... such as critical care, surgical and emergency departments. ...
(Date:5/24/2013)... missed more than half of recommended well-child visits had ... children who attended most of their visits, according to ... of Managed Care . The study included more than ... Children with chronic conditions like asthma and heart disease ... missed visits, according to the study. In fact, ...
Breaking Medicine News(10 mins):Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 3Health News:AICASA Signs Articulation Agreement with Old Dominion University to Create Study Abroad Program 2Health News:Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com 2Health News:Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com 3Health News:Young children who miss well-child visits are more likely to be hospitalized 2Health News:Young children who miss well-child visits are more likely to be hospitalized 3
... Kathleen Doheny HealthDay Reporter , MONDAY, ... may help breast cancer patients and their doctors ... mastectomy. One study finds that about half ... had a mastectomy with immediate reconstruction develop complications ...
... , MONDAY, Sept. 20 (HealthDay News) -- The intravenous administration ... to treat hospitalized patients suffering from either severe headaches or ... Goadsby, of the Headache Group in the department of neurology ... findings in the Sept. 21 issue of Neurology ...
... soaking from Typhoon Fanapi, and NASA and JAXA,s TRMM satellite ... system before it made landfall this weekend. NASA,s Aqua and ... before the Taiwan landfall, and as it was making landfall ... Rainfall Measuring Mission satellite known as TRMM captured an image ...
... CLEMSON, S.C. A Clemson biochemist has received grants totaling ... cause cancer and genetic illnesses. The U.S. Department of Defense ... Cao three-year funding to investigate two DNA repair pathways. ... understand the basic mechanisms of DNA repair but also help ...
... BETHESDA, Md., Sept. 20, 2010 The American Society for ... of the National Institute of General Medical Sciences, the winner ... Award. Berg will receive the award this evening at an ... "Dr. Berg has been a true champion of investigator-initiated research, ...
... of Utah determined that the 2009 pandemic influenza A ... children than the seasonal flu. The most common ... of the study, the most extensive evaluation of neurological ... the September issue of Annals of Neurology , ...
Cached Medicine News:Health News:Breast Reconstruction After Mastectomy: Now or Later? 2Health News:Breast Reconstruction After Mastectomy: Now or Later? 3Health News:IV Aspirin Drip Appears to Be Safe, Effective for Migraine 2Health News:NASA captures very heavy rain in Typhoon Fanapi and 2 landfalls 2Health News:Biochemist studies DNA repair with $787,000 in grants 2Health News:National Institute of General Medical Sciences chief wins prestigious public service award 2Health News:Higher incidence of seizures seen in children with H1N1 virus compared to seasonal flu 2
Silver Foley Catheter 2-way...
Foley Catheters (Latex) 3-Way...
Coude Foley Catheters (Latex) 2-Way Red...
Silicone-Coated Foley Catheter 2-Way...
Medicine Products: